The materials described on this page are research-grade reference peptides supplied strictly for in-vitro and other controlled laboratory research. They are not for human or animal consumption, are not FDA approved, and are not drugs, supplements, cosmetics, or treatments for any condition. This article is third-person science education explaining the analytical methods behind a purity figure.
It does not describe or endorse taking, dosing, or administering any substance, and any question about human safety belongs with a licensed clinician rather than with a research supplier.
What a Purity Figure Actually Reports
A number such as 98 percent printed on a certificate is not a general statement about quality. It is the output of a specific measurement, performed by a specific method, on a specific batch of material, and it answers a narrower question than most readers assume. Understanding what that question is turns the figure from a marketing number into usable analytical information.
In nearly all research peptide documentation, the purity figure comes from reversed-phase high performance liquid chromatography, usually abbreviated HPLC. What it reports is the proportion of ultraviolet-absorbing material in the injected sample that eluted as the main peak, relative to all ultraviolet-absorbing material detected across the run. That framing contains three important limits at once: it is relative rather than absolute, it counts only what absorbs ultraviolet light at the chosen wavelength, and it counts only what the column actually separated and eluted within the run time.
This is why purity and identity are two different claims requiring two different instruments. HPLC can report that a sample is 98 percent one substance without establishing that the substance is the peptide named on the label. Establishing identity is the job of mass spectrometry. A certificate that reports only one of the two is answering only half the question, and both halves matter for interpreting an experiment. Broader context on why documentation matters for research material is at Certificate of Analysis.
- Purity by HPLC: the fraction of detected ultraviolet-absorbing material that eluted as the main peak.
- Identity by mass spectrometry: confirmation that the molecular mass matches the expected sequence.
- Lot specificity: both figures describe one batch, not a product line or a representative sample.
- Not covered by either method alone: water content, counterion content, residual solvent, and endotoxin.
- Net peptide content: the actual mass of peptide in a vial, which differs from the purity percentage.
Reversed-Phase HPLC: The Separation Step
High performance liquid chromatography separates the components of a mixture by pushing the dissolved sample through a packed column under pressure. In the reversed-phase configuration standard for peptides, the packing material is nonpolar, commonly silica particles bonded with carbon chains of a defined length such as C18, and the mobile phase carrying the sample through is comparatively polar, typically water and acetonitrile with an acidic modifier.
Separation happens because different molecules partition differently between the stationary packing and the moving liquid. A more hydrophobic molecule spends more time associated with the nonpolar packing and therefore moves through the column more slowly. A more polar molecule moves through faster. Since peptides differ in hydrophobicity according to their amino acid composition, sequence variants that differ by even a single residue frequently separate, which is the property that makes the method useful for this class of compound.
The mobile phase composition is typically changed during the run, a technique called gradient elution, starting with a more polar mixture and increasing the proportion of organic solvent over time. This pulls progressively more hydrophobic components off the column in sequence rather than leaving strongly retained material stuck on the packing. As each component exits, it passes a detector, and the resulting trace of detector response against time is the chromatogram.
Why Wavelength Selection Matters
Peptide HPLC detection normally uses ultraviolet absorbance at a low wavelength, commonly around 214 nanometers, because the peptide bond itself absorbs there. Higher wavelengths such as 280 nanometers are absorbed mainly by aromatic residues, so a peptide containing no tryptophan, tyrosine, or phenylalanine would barely register. This is a practical reason a method section matters: a purity figure obtained at a wavelength poorly matched to the sample can understate or overstate contamination depending on what the impurities contain.
How a Percentage Is Calculated From a Chromatogram
The chromatogram is a series of peaks. Each peak represents material reaching the detector at a particular time, and the area under a peak is proportional to how much ultraviolet-absorbing material it contains. Purity is calculated as area normalization: the area of the main peak divided by the total area of all integrated peaks, expressed as a percentage.
Several consequences follow directly from that arithmetic. A contaminant that does not absorb at the detection wavelength contributes nothing to the denominator and is therefore invisible to the calculation, so it cannot lower the reported purity no matter how much of it is present. A contaminant that never elutes within the run window is equally invisible. And a contaminant that co-elutes with the main peak, meaning it exits the column at the same time, is counted as part of the main peak and inflates the figure rather than reducing it.
Peak integration also involves judgment. Where the analyst sets the baseline, whether small peaks are integrated or dismissed as noise, and how partially overlapping peaks are divided all affect the final percentage. Two competent analysts working from the same raw data can report figures that differ slightly. This is not a flaw in the method so much as a reason to treat a purity figure as a measurement with a method behind it rather than as an exact physical constant.
Mass Spectrometry: Identity Rather Than Purity
Mass spectrometry answers the question HPLC cannot: whether the material is the molecule it is supposed to be. The instrument ionizes the sample, accelerates the resulting ions through an electric or magnetic field, and measures the mass-to-charge ratio of what arrives at the detector. Because every peptide sequence has a calculable molecular mass derived from its constituent amino acids, an observed mass that matches the calculated value is direct evidence of identity.
Peptides are typically analyzed by one of two ionization approaches. Electrospray ionization produces multiply charged ions and is commonly coupled directly to a liquid chromatography system, so the separation and the identification happen in one workflow. Matrix-assisted laser desorption ionization, usually abbreviated MALDI, embeds the sample in a crystalline matrix and uses a laser pulse to generate predominantly singly charged ions, producing a spectrum that is often simpler to read for a single purified compound.
Mass confirmation has a specific and important limitation. Two different molecules can share the same molecular mass. Sequence isomers, which contain the same amino acids arranged in a different order, are the clearest case, and certain amino acid substitutions produce mass differences too small for a low-resolution instrument to resolve. Where sequence confirmation rather than mass confirmation is required, tandem mass spectrometry fragments the molecule and reads the masses of the fragments, reconstructing sequence information from the pattern.
What Neither Method Captures
The most consequential gap in a standard purity figure is that a lyophilized peptide vial does not contain only peptide. Freeze-dried peptide retains bound water, and peptides synthesized by standard solid-phase methods are usually isolated as salts, most often trifluoroacetate, which contributes mass that is not peptide. The combined effect is that a vial labeled with a given milligram quantity and reported as highly pure by HPLC can contain meaningfully less actual peptide than the label figure suggests.
The measurement that addresses this is net peptide content, sometimes reported as peptide content by amino acid analysis or by nitrogen determination. It is a different measurement from chromatographic purity and answers a different question: not what proportion of the detected material is the target, but what proportion of the total vial mass is peptide at all. A certificate reporting a high HPLC purity and no peptide content figure has left that question open.
Several other attributes fall outside both methods entirely. Residual solvents from synthesis and purification require gas chromatography to quantify. Endotoxin and microbial burden require their own specific assays and are not implied by any chromatographic result. Water content is typically measured by Karl Fischer titration. None of these is captured by an HPLC percentage, and a preparation can be chromatographically excellent while carrying a problem in one of them.
- Counterion content, commonly trifluoroacetate, contributing non-peptide mass to the vial.
- Residual water retained after lyophilization, measured separately by Karl Fischer titration.
- Residual synthesis and purification solvents, quantified by gas chromatography.
- Endotoxin and microbial burden, requiring dedicated assays rather than chromatography.
- Non-ultraviolet-absorbing contaminants, which cannot appear in an area normalization calculation.
- Strongly retained material that does not elute inside the chromatographic run window.
Reading a Certificate of Analysis Line by Line
A certificate is a data document rather than an assurance statement, and it is read most usefully by checking what each line actually asserts. The single most important attribute is lot specificity. A certificate describing a different batch says nothing about the vial in hand, however good the numbers on it are, because purity is a property of a production run rather than of a product name.
The method section deserves as much attention as the result. A purity figure without a stated column, gradient, and detection wavelength is a number without a measurement behind it, and it cannot be compared meaningfully against a figure produced under different conditions. Similarly, an identity confirmation is more informative when the observed mass is reported alongside the calculated mass, because the comparison is the evidence and the conclusion alone is not.
For research peptides the identity line carries particular weight where compound families share close structural relationships. Within the growth hormone secretagogue family, for instance, several closely related hexapeptides are routinely discussed together, and a preparation can be genuinely pure while being the wrong molecule for the protocol. That failure mode is not visible in a purity percentage and is resolved only by identity confirmation. The distinctions in that particular family are set out in the GHRP family comparison.
- Lot or batch number matching the vial physically in hand.
- Test date and, where given, retest or expiry date for the analysis itself.
- Purity result stated with the method: column chemistry, gradient, and detection wavelength.
- Identity result stated with both the observed and the calculated molecular mass.
- Net peptide content, where reported, distinguishing peptide mass from total vial mass.
- Appearance and, where relevant, water content and residual solvent results.
Why a Generic Certificate Is Not Evidence
A certificate that carries no lot number, or that is presented as representative of a product rather than as the analysis of a specific batch, is a template rather than a measurement. It may accurately describe what a manufacturing process typically produces, and that is not the same claim as describing what a given vial contains. Batch variation is the entire reason lot-specific testing exists.
The same reasoning applies to an undated certificate. Peptides degrade, and the rate depends on sequence, storage conditions, and time. An analysis performed on a batch at the point of manufacture describes the material at that moment. Without a date, a reader cannot judge how much of the interval between synthesis and use the figure is expected to cover, which matters most for sequences known to be chemically fragile.
The practical consequence for a research laboratory is procedural rather than adversarial. Documentation is retained alongside the experimental record so that an anomalous result can later be checked against the material that produced it. A result that cannot be traced to a characterized lot is harder to defend and harder to reproduce. Answer-first coverage of testing scope and what is and is not included is collected at purity testing and COA.
Why Purity Determines Whether a Result Is Interpretable
Purity is a precondition for attribution rather than a documentation formality. An experiment run on impure material still produces a number. Instruments do not refuse to record data because the input was poorly characterized. What is lost is not the measurement but the ability to attribute it, because an effect observed in an assay may belong to a synthesis byproduct, a truncated sequence, a residual solvent, or an uncharacterized counterion rather than to the compound named on the label.
This becomes most acute where the effect under study is small. A large, robust response can survive a modest amount of contamination without changing the conclusion. A subtle dose-response relationship, a small difference between two closely related compounds, or a low-magnitude signal in a cell culture model can be produced or erased by a contaminant present at a few percent. The experiments most in need of well-characterized material are frequently the ones where contamination is least likely to be noticed.
Reproducibility follows the same logic. Two laboratories running the same protocol on material from different lots may report different results for reasons that have nothing to do with either protocol. Where lot documentation exists on both sides, that divergence is a tractable question. Where it does not, the disagreement cannot be resolved at all. Related guides are collected at learn, answer-first topics at questions, and account and availability information at order.
Create a free research account to view current pricing and bundles and place an order.
Frequently asked questions
What does a 98 percent purity figure on a peptide certificate mean?
It means that in a reversed-phase HPLC run, 98 percent of the integrated ultraviolet-absorbing peak area eluted as the main peak. It is a relative measurement of detected material, not an absolute statement about vial contents. It does not account for contaminants that do not absorb at the detection wavelength, material that does not elute within the run, water, counterion salt, or residual solvents, and it does not by itself establish that the main peak is the intended molecule.
What is the difference between HPLC purity and mass spectrometry identity?
HPLC separates a mixture and reports how much of the detected material is the dominant component, answering how pure the sample is. Mass spectrometry measures mass-to-charge ratio and reports whether the molecular mass matches the expected sequence, answering what the sample is. A preparation can be highly pure and still be the wrong compound, which is why research documentation normally reports both measurements rather than either one alone.
Why is reversed-phase chromatography used for peptides?
Reversed-phase separation uses a nonpolar stationary phase and a comparatively polar mobile phase, so molecules separate by hydrophobicity. Peptides differ in hydrophobicity according to their amino acid composition, which means sequence variants differing by even a single residue often separate into distinct peaks. That resolving power is what makes the method suitable for detecting truncated sequences and synthesis-related byproducts in this class of compound.
Can a contaminant be invisible to an HPLC purity test?
Yes, in three distinct ways. A contaminant that does not absorb ultraviolet light at the detection wavelength contributes no peak area and cannot affect the calculation. A contaminant that remains bound to the column and does not elute within the run window is never detected. And a contaminant that co-elutes with the main peak is integrated as part of it, which raises the reported purity rather than lowering it.
What is net peptide content and why is it reported separately?
Net peptide content is the proportion of total vial mass that is actually peptide, as opposed to bound water and counterion salt such as trifluoroacetate left from synthesis and purification. It is measured by amino acid analysis or nitrogen determination rather than by chromatography. It answers a different question from purity: purity describes the composition of the detected material, while peptide content describes how much peptide the vial holds.
Does mass spectrometry confirm the amino acid sequence?
A standard mass measurement confirms molecular mass, not sequence. Two molecules containing the same amino acids in a different order share the same mass, and some substitutions produce mass differences too small for a low-resolution instrument to resolve. Sequence confirmation requires tandem mass spectrometry, which fragments the molecule and reconstructs sequence information from the masses of the resulting fragments.
Why does lot specificity matter on a certificate of analysis?
Purity and identity are properties of a specific production batch rather than of a product name, and batch variation is the reason lot-specific testing exists at all. A certificate without a lot number, or one presented as representative of a product line, describes what a process typically yields rather than what a particular vial contains. Matching the lot number on the certificate to the lot number on the vial is the step that makes the document evidence.
How does purity affect whether an experiment can be interpreted?
An experiment on poorly characterized material still produces data; what is lost is the ability to attribute the result. An observed effect may belong to a byproduct, a truncated sequence, or a residual solvent rather than to the labeled compound. The risk is highest where the effect under study is small, because a contaminant present at a few percent can create or erase a subtle signal without being obvious in the result.
All guides · Order research peptides
External references: U.S. Food and Drug Administration · Peptide (Wikipedia)